Dilution of Share Value Due to Exercise of Stock Acquisition Rights
First written in FY2016. 15 of 17 entries say "Restated". Latest entry: FY2024-Q2.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
15 other companies' latest entry also says "Restated".
- FY2024-Q2RestatedAnnual report
「During the first six months of the fiscal year, there were no significant changes in the occurrence of the major risks that management recognizes as potentially having a material impact on the financial position, operating results and cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
The filing states that there was no material change in the risk of dilution of share value from the exercise of stock acquisition rights. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no occurrences of major risks that management recognizes could materially affect the financial condition, operating results or cash flow of the consolidated companies among the matters concerning the business and financial conditions described in the quarterly report, nor were there any material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
It states that there has been no material change regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2023-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no occurrences of major risks that management recognizes could materially affect the financial condition, operating results or cash flow of the consolidated companies among the matters concerning the business and financial conditions described in the quarterly report, nor were there any material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
It states that there has been no material change regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2022RestatedAnnual report
「The Company has previously issued stock acquisition rights pursuant to Articles 236, 238 and 239 of the Companies Act. If these rights are exercised, the value of the Company's equity could be diluted, potentially affecting its share price.」
Continues to report the risk of dilution of equity value from the exercise of previously issued stock acquisition rights. - FY2022-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no occurrences of major risks that management recognizes could materially affect the financial condition, operating results or cash flow of the consolidated companies among the matters concerning the business and financial conditions described in the quarterly report, nor were there any material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
It states that there has been no material change regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
It states that there has been no material change regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2021-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no occurrences of major risks that management recognizes could materially affect the financial condition, operating results or cash flow of the consolidated companies among the matters concerning the business and financial conditions described in the quarterly report, nor were there any material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
It states that there has been no material change regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2020RestatedAnnual report
「The Company has previously issued stock acquisition rights pursuant to Articles 236, 238 and 239 of the Companies Act. If these rights are exercised, the value of the Company's equity could be diluted, potentially affecting its share price.」
Maintains the risk of dilution of equity value from the exercise of previously issued stock acquisition rights. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
No material changes are reported regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2020-Q2RestatedAnnual report
「During the cumulative second-quarter period, no matters arose that could materially affect investors' decisions. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes are reported regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2020-Q1RestatedAnnual report
「During the cumulative first-quarter period, no matters arose that could materially affect investors' decisions. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes are reported regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2019-Q1RestatedAnnual report
「During the cumulative first-quarter period, no matters arose that could materially affect investors' decisions. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes are reported regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2018RestatedAnnual report
「The Company has previously issued stock acquisition rights pursuant to Articles 236, 238 and 239 of the Companies Act. If these rights are exercised, the value of the Company's equity could be diluted, potentially affecting its share price.」
Restates the risk of dilution of equity value from the exercise of stock acquisition rights. The number of shares remaining subject to the 2017 stock options is 982,500. - FY2018-Q3RestatedAnnual report
「During the nine months ended the third quarter, no new business or other risks arose. There were also no significant changes to the business or other risks described in the annual securities report for the previous fiscal year.」
No material changes are reported regarding the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2018-Q2WorsenedAnnual report
「Number of stock acquisition rights (units) 10,000 Number of shares underlying the stock acquisition rights (shares) 1,000,000 Exercise period of the stock acquisition rights From 16 September 2019 To 15 September 2024」
Reports 10,000 stock acquisition rights approved on 13 September 2017 and 1,000,000 underlying shares, newly specifying the shares subject to potential future dilution of equity value. - FY2017RestatedAnnual report
「The Company has previously issued stock acquisition rights pursuant to Articles 236, 238 and 239 of the Companies Act. If these rights are exercised, the value of the Company's equity could be diluted, potentially affecting its share price.」
Restates the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2016First statedAnnual report
「The Company has previously issued stock acquisition rights pursuant to Articles 236, 238 and 239 of the Companies Act. If these rights are exercised, the value of the Company's equity could be diluted, potentially affecting its share price.」
Reports 56,506,084 shares and 57,454,884 shares issuable upon exercise of stock acquisition rights as potential shares.